Current landscape of immune-mediated inflammatory rheumatic diseases in Brazil's public and private systems: retrospective cohort study - PubMed
7 hours ago
- #Healthcare Costs
- #Epidemiology
- #Rheumatology
- Study focused on epidemiology, outcomes, and costs of four immune-mediated inflammatory rheumatic diseases (IMIRDs) in Brazil's public and private healthcare systems from 2018 to 2022.
- Rheumatoid arthritis (RA) had the highest incidence (19.9-24.9 per 100,000) and prevalence (95.7-136.8 per 100,000).
- Systemic lupus erythematosus (SLE) had the highest hospitalisation (7.2%) and lethality rates (8.7%), along with the highest average outpatient cost (US$440.9 per patient).
- In the private healthcare system, RA and SLE accounted for the most hospitalisations (36.3% each).
- SLE had the highest proportion of emergency hospitalisations (70.5%), while psoriatic arthritis (PsA) had the highest proportion of elective hospitalisations (61.8%).
- The study highlights the growing burden of IMIRDs on Brazil's healthcare systems due to rising prevalence rates.